AIM
SNTI icon

ARK Investment Management’s Senti Biosciences Holdings SNTI Stock Holding History

ARK Investment Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28
Closed -$97 – 198
2024
Q4 		$97 Sell
28
-176,638
-100% -$564K ﹤0.01% 181
2024
Q3 		$399K Buy
176,666
+18,089
+11% +$47.8K ﹤0.01% 166
2024
Q2 		$438K Sell
158,577
-4,515
-3% -$14.6K ﹤0.01% 170
2024
Q1 		$615K Sell
163,092
-33,894
-17% -$151K ﹤0.01% 199
2023
Q4 		$1.3M Buy
196,986
+14,378
+8% +$56.1K 0.01% 195
2023
Q3 		$754K Sell
182,608
-374
-0.2% -$2.57K 0.01% 198
2023
Q2 		$1.15M Sell
182,982
-7,165
-4% -$69.9K 0.01% 195
2023
Q1 		$2.24M Sell
190,147
-2,436
-1% -$37.9K 0.02% 163
2022
Q4 		$2.72M Sell
192,583
-16,187
-8% -$395K 0.02% 148
2022
Q3 		$4.53M Sell
208,770
-11,458
-5% -$226K 0.03% 137
2022
Q2 		$21.9M Sell
220,228
-7,620
-3% -$612K 0.13% 86
2022
Q1 		$22.5M Sell
227,848
-8,420
-4% -$831K 0.09% 105
2021
Q4 		$23.3M Buy
236,268
+3,556
+2% +$355K 0.07% 130
2021
Q3 		$23.1M Buy
232,712
+24,061
+12% +$2.37M 0.06% 136
2021
Q2 		$20.7M Buy
+208,651
New +$20.8M 0.04% 167

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ARK Investment Management's SNTI Position: Q1 2025 in Review

ARK Investment Management sold out of Senti Biosciences Holdings (SNTI) in Q1 2025, closing a stake of 28 shares — an estimated $97 sold.

ARK Investment Management first reported a position in SNTI in Q2 2021 and held it in 15 quarters. The position peaked at $23.3M in Q4 2021. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2025.

  • ARK Investment Management reported no remaining Senti Biosciences Holdings position as of Q1 2025 after selling out during the quarter.
  • ARK Investment Management sold 28 Senti Biosciences Holdings shares in Q1 2025, an estimated $97.
  • ARK Investment Management first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 15 quarters.
  • ARK Investment Management's Senti Biosciences Holdings position peaked at $23.3M in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2025.

Based on ARK Investment Management's 13F filing for Q1 2025, filed 7 May 2025.